Congress Weighs Repeal of Tax Credit for Rare Disease Drugs. Drugs (Pharmaceuticals), Federal Taxes (US), Corporate Taxes, Tax Credits, Deductions and Exemptions, Biotechnology and Bioengineering, House of Representatives, Senate, Medicine and Health, United States Politics and Government